Skip to Content

LabMed, Volume 3, Issue 1

2026 March - 7 articles

  • Issues are regarded as officially published after their release is announced to the table of contents alert mailing list .
  • You may sign up for email alerts to receive table of contents of newly released issues.
  • PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.

Articles (7)

  • Review
  • Open Access

Lung Cancer Prediction with Machine Learning, Deep Learning and Hybrid Techniques: A Survey

  • Abdullah Bin Zahid,
  • Fakhar Un Nisa,
  • Ahmad Kamran Malik and
  • Nafees Qamar
LabMed2026, 3(1), 7;https://doi.org/10.3390/labmed3010007 
(registering DOI)

28 February 2026

Lung cancer remains one of the most formidable health challenges globally, with significant morbidity and mortality rates. Despite advancements in diagnostic and treatment technologies, the disease’s high prevalence, late-stage detection, and c...

  • Case Report
  • Open Access
179 Views
7 Pages

Severe Bleeding Due to an Acquired FXIII Inhibitor in an Otherwise Healthy Patient

  • Bianca Santonastaso,
  • Hannah Spector,
  • Christine Cahill,
  • Khaled Refaai,
  • Frank Akwaa,
  • Jainulabdeen J. Ifthikharuddin,
  • Gahyun Gim and
  • Majed A. Refaai

13 February 2026

A 75-year-old male was admitted with worsening anemia and spontaneous bruising in the left abdominal wall and paraspinal region. Laboratory workup revealed low factor XIII (FXIII) activity levels. Cryoprecipitate transfusions raised his FXIII level,...

  • Article
  • Open Access
413 Views
14 Pages

Predictors and Trends of Hepatitis B Virus Transmissions in Selected Regions of Kenya

  • Missiani Ochwoto,
  • Raphael O. Ondondo,
  • Lydia Moraa Matoke,
  • Gladys Tuitoek,
  • Elizabeth Ogwora,
  • Samuel W. Omari,
  • Haron Mong’are,
  • Francis Otieno Onoka,
  • Esther Sigilai and
  • Damaris Matoke-Muhia
  • + 4 authors

2 February 2026

Hepatitis B virus (HBV) infection is a silent epidemic; many infected people are asymptomatic and not aware of the infection. In 2022, it was reported that approximately 254 million people were living with chronic HBV infection globally, majority bei...

  • Systematic Review
  • Open Access
326 Views
25 Pages

30 January 2026

Measurement of vitamin E levels is used to evaluate the health status in humans. For routine analytics in clinical laboratories, an accurate, quick, and simple determination method is required. An option for the quantification of vitamin E (α-t...

  • Article
  • Open Access
223 Views
11 Pages

29 January 2026

Plasma cell disorders often have urinary excretion of monoclonal immunoglobulins and renal injury that are evaluated using total protein assays and electrophoresis. Proteinuria was evaluated for 100 patients with plasma cell disorders and 24 h collec...

  • Article
  • Open Access
262 Views
24 Pages

14 January 2026

Source plasma centers sustain hematology therapeutics by safeguarding testing, traceability, and cold-chain integrity before fractionation. Despite regulatory requirements (21 CFR 606/640; EU Directive 2005/62/EC), published pre-operational validatio...

  • Article
  • Open Access
370 Views
13 Pages

Stewardship in Action: An Evaluation of Antibiotic De-Escalation Prescribing After Positive Pneumococcal Urinary Antigen Testing in a Safety Net Health System

  • Mehak Bhatia,
  • Katherine Davanzo,
  • Paul Kim,
  • Jyothik Varun Inampudi,
  • Mazhar Shapoo,
  • Marco Scipione,
  • Sorabh Dhar and
  • Lea Monday

31 December 2025

The Infectious Diseases Society of America (IDSA) guidelines for community-acquired pneumonia (CAP) recommend pneumococcal urinary antigen testing (UAT) for a subset of inpatients admitted with pneumonia. Despite this, UAT testing is frequently perfo...

Get Alerted

Add your email address to receive forthcoming issues of this journal.

XFacebookLinkedIn
LabMed - ISSN 2813-9038